The same five careers, seven different job markets

The largest single market by headcount and pay. The Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research are the reference points for most drug and biologic work.

Hubs: Boston and Cambridge, New Jersey, the San Francisco Bay Area, Research Triangle Park, San Diego, Chicago.

Sponsorship: possible at large employers but genuinely competitive, and small biotechs frequently will not sponsor at all. Cap-subject visa timing constrains hiring cycles.

The European Medicines Agency, based in Amsterdam, sits alongside national competent authorities in each member state. Pharmacovigilance obligations here are unusually well codified, which makes EU safety experience portable.

Hubs: Basel and the Swiss corridor, Ireland, Germany, Denmark, the Netherlands, Barcelona.

Sponsorship: the EU Blue Card gives a defined skilled-worker route, and several countries actively court scientific talent. Language expectations vary sharply by country and by function.

Now an independent regulator post-Brexit, which created regulatory affairs demand as companies maintain separate UK and EU submissions.

Hubs: Cambridge, London, Macclesfield, Stevenage.

Sponsorship: the Skilled Worker route is well established and widely used by pharmaceutical employers.

One of the fastest-growing employment markets in these functions, driven heavily by global capability centres that run safety, regulatory and clinical operations for multinational sponsors.

Hubs: Hyderabad, Bengaluru, Mumbai, Pune, Chennai.

Why it matters globally: for many clinicians this is the most accessible entry into an international pharmaceutical career without relocating at all.

A smaller market with a meaningful affiliate presence, often serving as a regional base for North American medical affairs.

Hubs: Toronto and Mississauga, Montreal, Vancouver.

Sponsorship: generally more accessible than the United States, with established skilled-migration pathways. French is a real advantage in Quebec.

Japan's Pharmaceuticals and Medical Devices Agency governs one of the largest pharmaceutical markets in the world, while Australia's Therapeutic Goods Administration anchors a smaller but well-developed market.

Hubs: Tokyo, Osaka, Sydney, Melbourne, Singapore as a regional headquarters.

Language: Japanese fluency is usually non-negotiable for local roles; Singapore and Australia operate in English.

Growing affiliate and regional-office presence, particularly in the United Arab Emirates and Saudi Arabia, often covering several countries from one base.

Hubs: Dubai, Riyadh, with Cairo and Johannesburg serving wider regional roles.

Character of the work: roles tend to be broader than in mature markets, with one person covering ground that several would cover elsewhere — excellent for range early in a career.